Retrospective Analysis of Real-World Treatment Patterns and Survival Outcomes for Non-small Cell Lung Cancer Patients in Thailand

被引：0
|
作者：
Supaattagorn, S. [1 ]
Maneenil, K. [1 ,2 ]
机构：
[1] Rajavithi Hosp, Dept Med, Oncol unit, Bangkok, Thailand
[2] Rangsit Univ, Coll Med, Bangkok, Thailand
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Real-world outcomes; NSCLC; treatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP10.01-05
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [21] Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa-KINDLE Study
    Jazieh, A. R.
    Saglam, E. Kaytan
    Onal, H. C.
    Abdelkader, Y.
    Gaafar, R.
    Dawoud, E.
    Nassar, M.
    Alshorbagy, D.
    El Ashry, H.
    Elsayed, M.
    CLINICAL LUNG CANCER, 2022, 23 (04) : 364 - 373
  • [22] EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes
    Xu, Haiyan
    Yang, Guangjian
    Li, Weihua
    Li, Junling
    Hao, Xuezhi
    Xing, Puyuan
    Yang, Yaning
    Wang, Yan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] The real-world comparison of non-small cell lung cancer survival outcomes depending on immunotherapy treatment and PD-L1 expression level
    Ondrusova, Martina
    Suchansky, Martin
    Svidova, Sona VaNDOR
    Chowaniecova, Gabriela
    Mrinakova, Bela
    Sekeresova, Monika
    Juskanic, Dominik
    Ondrus, Dalibor
    Senitko, Michal
    NEOPLASMA, 2024, 71 (05) : 498 - 508
  • [24] Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world study
    Endo, Satoshi
    Honda, Takayuki
    Sato, Kazuaki
    Kubota, Natsushi
    Kamoshida, Tatsuhiko
    Mochizuki, Akifumi
    Fujii, Mayumi
    Ochi, Junichi
    Miyazaki, Yasunari
    Tsukada, Yoshikazu
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37
  • [25] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Molife, Cliff
    Winfree, Katherine B.
    Bailey, Hollie
    D'yachkova, Yulia
    Forshaw, Cameron
    Kim, Sangmi
    Taipale, Kaisa-Leena
    Puri, Tarun
    ADVANCES IN THERAPY, 2023, 40 (07) : 3135 - 3168
  • [26] Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country
    Poh, Mau Ern
    How, Soon Hin
    Ho, Gwo Fuang
    Pang, Yong Kek
    Hasbullah, Harissa H.
    Tho, Lye Mun
    Nor, Ibtisam Muhamad
    Lim, Bee Chiu
    Ho, Kean Fatt
    Thiagarajan, Muthukkumaran
    Samsudin, Azlina
    Omar, Azza
    Ong, Choo Khoon
    Soon, Sing Yang
    Tan, Justin Yu Kuan
    Abidin, Muhammad Adil Zainal
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 31 - 41
  • [27] Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations
    Gorgens, S.
    Schreibmann, E.
    Behera, M.
    Steuer, C.
    Pillai, R.
    Owonikoko, T.
    Shelton, J.
    Ramalingam, S.
    Curran, W.
    Higgins, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S588 - S589
  • [28] Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations
    Shi, Chao
    Xing, Ruyue
    Li, Mengmeng
    Feng, Junnan
    Sun, Rui
    Wei, Bing
    Guo, Yongjun
    Ma, Jie
    Wang, Huijuan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare
    Yusuf, D.
    Walton, R.
    Hurry, M.
    Cheung, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S626 - S626
  • [30] Real-World Characteristics and Outcomes of ERBB2-Mutant Non-small Cell Lung Cancer in Latin America Patients
    Saldanha, E.
    De Lima, V. C. C.
    Corassa, M.
    Arrieta, O.
    Fares, A.
    Santana, L. Gil
    Soler, J. A.
    Chamorro, D.
    Rodriguez, J.
    Freitas, H.
    Cardona, A. F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S661 - S661
12345